Trial
NCT05079230
Study of Magrolimab Versus Placebo in Combination With Venetoclax and Azacitidine in Participants With Acute Myeloid Leukemia
Phase IIITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
Gilead Sciences
Collaborators
—
Condition
Acute Myeloid Leukemia
Intervention
Magrolimab
Why stopped
Study was terminated due to futility
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-04-04